NCT01729663 2015-09-02Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma PatientsLaboratorio Pablo Cassará S.R.L.Phase 2/3 Unknown108 enrolled